Lazard Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29M | Buy |
|
|||||
|
2025
Q1 | $22.3M | Buy |
|
|||||
|
2024
Q4 | $5.42M | Sell |
|
|||||
|
2024
Q3 | $7.37M | Sell |
|
|||||
|
2024
Q2 | $7.52M | Sell |
|
|||||
|
2024
Q1 | $19.3M | Sell |
|
|||||
|
2023
Q4 | $56.4M | Sell |
|
|||||
|
2023
Q3 | $68.3M | Sell |
|
|||||
|
2023
Q2 | $82.4M | Buy |
|
|||||
|
2023
Q1 | $85.3M | Buy |
|
|||||
|
2022
Q4 | $96.4M | Buy |
|
|||||
|
2022
Q3 | $77M | Sell |
|
|||||
|
2022
Q2 | $100M | Sell |
|
|||||
|
2022
Q1 | $108M | Buy |
|
|||||
|
2021
Q4 | $47.7M | Buy |
|
|||||
|
2021
Q3 | $34.7M | Sell |
|
|||||
|
2021
Q2 | $59.6M | Sell |
|
|||||
|
2021
Q1 | $103M | Sell |
|
|||||
|
2020
Q4 | $123M | Sell |
|
|||||
|
2020
Q3 | $637M | Buy |
|
|||||
|
2020
Q2 | $547M | Buy |
|
|||||
|
2020
Q1 | $473M | Buy |
|
|||||
|
2019
Q4 | $465M | Buy |
|
|||||
|
2019
Q3 | $279M | Sell |
|
|||||
|
2019
Q2 | $406M | Sell |
|
|||||
|
2019
Q1 | $482M | Sell |
|
|||||
|
2018
Q4 | $496M | Sell |
|
|||||
|
2018
Q3 | $619M | Sell |
|
|||||
|
2018
Q2 | $531M | Sell |
|
|||||
|
2018
Q1 | $658M | Buy |
|
|||||
|
2017
Q4 | $622M | Buy |
|
|||||
|
2017
Q3 | $607M | Sell |
|
|||||
|
2017
Q2 | $577M | Sell |
|
|||||
|
2017
Q1 | $1.01B | Sell |
|
|||||
|
2016
Q4 | $1.12B | Buy |
|
|||||
|
2016
Q3 | $892M | Buy |
|
|||||
|
2016
Q2 | $783M | Sell |
|
|||||
|
2016
Q1 | $810M | Buy |
|
|||||
|
2015
Q4 | $755M | Buy |
|
|||||
|
2015
Q3 | $731M | Buy |
|
|||||
|
2015
Q2 | $731M | Buy |
|
|||||
|
2015
Q1 | $734M | Buy |
|
|||||
|
2014
Q4 | $645M | Sell |
|
|||||
|
2014
Q3 | $643M | Sell |
|
|||||
|
2014
Q2 | $825M | Buy |
|
|||||
|
2014
Q1 | $812M | Buy |
|
|||||
|
2013
Q4 | $738M | Sell |
|
|||||
|
2013
Q3 | $840M | Sell |
|
|||||
|
2013
Q2 | $839M | Buy |
|